|
Volumn 22, Issue 2, 2014, Pages 848-855
|
Synthesis and biological evaluation of 6H-pyrido[2′,1′:2,3] imidazo[4,5-c]isoquinolin-5(6H)-ones as antimitotic agents and inhibitors of tubulin polymerization
|
Author keywords
6H Pyrido 2 ,1 :2,3 imidazo 4,5 c isoquinolin 5(6H) ones; Antitumor agents; Colchicine binding site; Inhibitors of tubulin polymerization
|
Indexed keywords
6 (1,3 BENZODIOXOL 5 YLMETHYL)PYRIDO[2',1':2,3]IMIDAZO[4,5 C]ISOQUINOLIN 5(6H) ONE;
6 (2 FURYLMETHYL)PYRIDO[2',1':2,3]IMIDAZO[4,5 C]ISOQUINOLIN 5(6H) ONE;
6 (2,4 DIMETHOXYBENZYL)PYRIDO[2',1':2,3]IMIDAZO[4,5 C]ISOQUINOLIN 5(6H) ONE;
6 (3,4 DIMETHOXYBENZYL)PYRIDO[2',1':2,3]IMIDAZO[4,5 C]ISOQUINOLIN 5(6H) ONE;
6 (4 METHOXYBENZYL) 11 METHYLPYRIDO[2',1':2,3]IMIDAZO[4,5 C]ISOQUINOLIN 5(6H) ONE;
6 (4 METHOXYBENZYL) 8 METHYLPYRIDO[2',1':2,3]IMIDAZO[4,5 C]ISOQUINOLIN 5(6H) ONE;
6 [2 (4 HYDROXYPHENYL)ETHYL]PYRIDO[2',1':2,3]IMIDAZO[4,5 C]ISOQUINOLIN 5(6H) ONE;
6 [2 (4 METHOXYPHENYL)ETHYL] 9 [(2 MORPHOLIN 4 YLETHYL)AMINO]PYRIDO[2',1':2,3]IMIDAZO[4,5 C]ISOQUINOLIN 5(6H) ONE;
6 [2 (4 METHOXYPHENYL)ETHYL] 9 [(PYRIDIN 2 YLMETHYL) AMINO]PYRIDO[2',1':2,3]IMIDAZO[4,5 C]ISOQUINOLIN 5(6H) ONE;
6 [2 (4 METHOXYPHENYL)ETHYL] 9 [(PYRIDIN 3 YLMETHYL) AMINO]PYRIDO[2',1':2,3]IMIDAZO[4,5 C]ISOQUINOLIN 5(6H) ONE;
6 [2 (4 METHOXYPHENYL)ETHYL] 9 [(PYRIDIN 4 YLMETHYL) AMINO]PYRIDO[2',1':2,3]IMIDAZO[4,5 C]ISOQUINOLIN 5(6H) ONE;
6 [2 (4 METHOXYPHENYL)ETHYL]PYRIDO[2',1':2,3]IMIDAZO[4,5 C]ISOQUINOLIN 5(6H) ONE;
6 [3 (4 METHOXYPHENYL)PROPYL]PYRIDO[2',1':2,3]IMIDAZO[4,5 C]ISOQUINOLIN 5(6H) ONE;
6 [4 (TRIFLUOROMETHOXY)BENZYL]PYRIDO[2',1':2,3]IMIDAZO[4,5 C]ISOQUINOLIN 5(6H) ONE;
6H PYRIDO[2',1':2,3] IMIDAZO[4,5 C]ISOQUINOLIN 5(6H) ONE DERIVATIVE;
9 (1H IMIDAZOL 1 YL) 6 [2 (4 METHOXYPHENYL)ETHYL]PYRIDO[2',1':2,3]IMIDAZO[4,5 C]ISOQUINOLIN 5(6H) ONE;
9 BROMO 6 (4 METHOXYBENZYL) 10 METHYLPYRIDO[2',1':2,3]IMIDAZO[4,5 C]ISOQUINOLIN 5(6H) ONE;
9 BROMO 6 (4 METHOXYBENZYL) 8 METHYLPYRIDO[2',1':2,3]IMIDAZO[4,5 C]ISOQUINOLIN 5(6H) ONE;
9 [[2 (DIETHYLAMINO)ETHYL]AMINO] 6 [2 (4 METHOXYPHENYL)ETHYL]PYRIDO[2',1':2,3]IMIDAZO[4,5 C]ISOQUINOLIN 5(6H) ONE;
9 [[3 (1H IMIDAZOL 1 YL)PROPYL]AMINO] 6 [2 (4 METHOXYPHENYL)ETHYL]PYRIDO[2',1':2,3]IMIDAZO[4,5 C]ISOQUINOLIN 5(6H) ONE;
ANTIMITOTIC AGENT;
COLCHICINE;
METHYL 3 (5 OXOPYRIDO[2',1':2,3]IMIDAZO[4,5 C]ISOQUINOLIN 6(5H) YL)PROPANOATE;
UNCLASSIFIED DRUG;
VINCRISTINE;
[(2 HYDROXYETHYL)AMINO] 6 [2 (4 METHOXYPHENYL)ETHYL]PYRIDO[2',1':2,3]IMIDAZO[4,5 C]ISOQUINOLIN 5(6H) ONE;
IMIDAZOLE DERIVATIVE;
ISOQUINOLINE DERIVATIVE;
PYRIDINE DERIVATIVE;
TUBULIN;
ANTIPROLIFERATIVE ACTIVITY;
ARTICLE;
BINDING SITE;
CONTROLLED STUDY;
CYTOTOXICITY;
DRUG STRUCTURE;
DRUG SYNTHESIS;
FLOW CYTOMETRY;
G2 PHASE CELL CYCLE CHECKPOINT;
HELA CELL;
HUMAN;
HUMAN CELL;
IC 50;
IMMUNOFLUORESCENCE;
IN VITRO STUDY;
M PHASE CELL CYCLE CHECKPOINT;
MICROTUBULE ASSEMBLY;
STRUCTURE ACTIVITY RELATION;
CELL CYCLE;
CELL PROLIFERATION;
CHEMICAL STRUCTURE;
CHEMISTRY;
DOSE RESPONSE;
DRUG EFFECTS;
DRUG SCREENING;
HELA CELL LINE;
METABOLISM;
POLYMERIZATION;
SYNTHESIS;
ANTIMITOTIC AGENTS;
CELL CYCLE;
CELL PROLIFERATION;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG SCREENING ASSAYS, ANTITUMOR;
HELA CELLS;
HUMANS;
IMIDAZOLES;
ISOQUINOLINES;
MOLECULAR STRUCTURE;
POLYMERIZATION;
PYRIDINES;
STRUCTURE-ACTIVITY RELATIONSHIP;
TUBULIN;
|
EID: 84892368345
PISSN: 09680896
EISSN: 14643391
Source Type: Journal
DOI: 10.1016/j.bmc.2013.12.004 Document Type: Article |
Times cited : (33)
|
References (24)
|